NCT02406287View on ClinicalTrials.gov

A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Healthy Subjects
Interventions
DRUG

Netarsudil (AR-13324) Ophthalmic Solution

Topical ophthalmic solution

DRUG

Netarsudil (AR-13324) Ophthalmic Solution Placebo

Ophthalmic solution once a day

Trial Locations (1)

07921

Aerie Pharmaceutical, Bedminster

Sponsors
All Listed Sponsors
lead

Aerie Pharmaceuticals

INDUSTRY

NCT02406287 - A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter